PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update

Roth Capital Downgrades PTC Therapeutics (PTCT) to Neutral

May 5, 2015 7:05 AM EDT

Roth Capital downgraded PTC Therapeutics (NASDAQ: PTCT) from Buy to Neutral with a price target of $63.00 (from $75.00).

For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.

Shares of PTC Therapeutics closed at $60.84 yesterday.

... More

PTC Therapeutics (PTCT) Reports Q1 Loss Per Share of $1.15

May 4, 2015 5:02 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q1 EPS of ($1.15), may not compare to the analyst estimate of ($1.20). Revenue for the quarter came in at $7.48 million versus the consensus estimate of $2.97 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

... More